Search

“Stamps.com, Inc. (STMP Nasdaq)—This California-based company ($575 million market cap) allows customers to pay for and print postage for a variety of letters and packages online. The 16-year-old firm gets solid marks from several of my models, including my Peter Lynch- and Motley Fool-based strategies. [The latter] methodology seeks companies...

BioLife Solutions (BLFS) reported yesterday afternoon and Q1 results beat expectations. Revenue was up 38.6% to $16.9 million (beating by $800K) while adjusted EPS of $0.01 beat by a penny. Management also bumped up full-year guidance, with revenue now expected in the $106 to $115 million range.

Our first move in 2020 is going to be to modestly reduce our exposure by dropping a few stocks that are looking weak right now.

The Dow hit a new high today, but marijuana stocks didn’t; their correction, which was richly deserved, is now one month old. And the fact is this correction is likely to run further, mainly because the broad market still needs a correction.

Yesterday, voters in all five states where it was on the ballot—Arizona, Mississippi, Montana, New Jersey and South Dakota—said they were in favor of legalization, and in every case, the majority vote was clearly positive, not even close.

There hasn’t been any real news about our stocks in the past week, but I’ve been watching the charts carefully, trying to decide whether it’s time to put some of our 35% cash back into the market, or to take more out, or to simply stand pat.

This afternoon we are making four ratings changes:

Life360 (LIF) Delivers Q3 Report

Private equity companies often use a “platform” strategy to deploy their tech stacks to smaller acquisitions, and I recently experienced how game-changing that could be for AI.

The market has been up, down and all over the place lately. So have our stocks. Oddly enough, from last Thursday’s close through yesterday’s close our portfolio is relatively unchanged—down just 2% using a simple average of each stock’s weekly return.

This year, individual stock performance has largely been driven by a single narrative: how well the underlying companies are positioned for a pandemic-striken world. Those with strong digital-economy businesses have surged, while those with physical-economy businesses have stalled, or worse.

In this issue we recommend a life insurance stock and talk about Dow laggards with rebound potential.

Winning stocks can be hard to find. But it can be even harder to hold on to winning stocks through all the ups and downs, and not sell too early.

The Contrary Opinion Forum in Vermont - the longest continuing investment conference in America - has all but died. Here are my fondest memories from 30 years of attending the annual conference.

The following four stocks have been down and out for quite some time. Which one is the most likely turnaround stock candidate?

The business of educating America has been expanding quickly during the past decade. Two of my favorite education stocks are Apollo Group (APOL) and ITT Educational (ESI).

The important thing to remember is that the ideal revolutionary stock has the potential to get very much larger.

Believe it or not, 2013 is already half over. And that means one thing for us: it’s time to check in on the performance of our Dick Davis Digest Top Picks for 2013. At the beginning of every year, we ask our Dick Davis Digest contributing experts to send us their...

Here are two healthcare stocks that are currently undervalued and sell at bargain prices.

Awareness of cannabis is definitely up, but there are still major friction points, which will continue at least until the U.S. government legalizes marijuana as it has just legalized hemp.

Our Emerging Markets Timer is still positive and constructive, though the EEM was essentially flat during the last week.